Clinical Trial Update: Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Stereotactic Radiotherapy) in Patients With Unresectable Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating mFOLFIRINOX with SBRT for unresectable locally advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Unresectable Pancreatic Cancer

Drugs mentioned

• mFOLFIRINOX

Snippet

Sponsor: Medical University of Silesia | Conditions: Cancer of Pancreas, Unresectable Pancreatic Cancer | Phase 2 | Status: COMPLETED